|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
AerovectRx Corp., of Atlanta, received notice of allowance for a patent covering claims relating to its platform nebulizer technology, which was licensed from the Centers for Disease Control and Prevention. The technology aims to deliver therapies and vaccines in an easy-to-breathe mist.
Amedex Therapeutics Inc., of Wilsonville, Ore., was issued a patent relating to its NuBiotics portfolio, anti-infective products targeted to bacterial infections and encompassing antibiotic resistant bacteria, such as methicillin-resistant Staphylococcus aureus, and certain viral indications, including avian influenza, Epstein-Barr virus and hepatitis B and C.
ARC ...
Related newspaper, magazine, and journal articles:
|